Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patients. (Q42992737)
Jump to navigation
Jump to search
scientific article published on 23 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patients. |
scientific article published on 23 October 2009 |
Statements
Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patients (English)
Patrick Marcellin
Norman Gitlin
Jamie Heise
Deanine G Halliman
Eric Chun
Maribel Rodriguez-Torres
23 October 2009